Abstract | BACKGROUND:
Enhanced Recovery After Surgery (ERAS) programs have demonstrated improved outcomes in noncardiac surgery. More recently, ERAS has been applied to cardiac surgery with promising results. We have implemented cardiac ERAS at our community-based program, aiming to improve all phases of care, and now report our early results. METHODS: RESULTS: ERAS patients required significantly less opioids captured as total morphine milligram equivalents ( MME) (median 35.0 vs 75.3; P < .001), less nausea as determined by fewer total ondansetron rescue doses (median 0 vs 0.5; P = .011), and less lightheadedness (P = .028) compared with pre-ERAS patients. Postoperative mobility was significantly better (postoperative day 4: 95% vs 81%; P = .013) and postoperative length of stay was lower for ERAS care but did not reach statistical significance (median 4 days vs 5 days; P = .06). There was no difference in pain or glucose control or in early extubation. CONCLUSIONS: Cardiac ERAS significantly decreased opioid use, nausea, and lightheadedness and improved functional outcome for cardiac surgical patients in a community hospital.
|
Authors | Rawn Salenger, Sari D Holmes, Amanda Rea, Jennifer Yeh, Kate Knott, Rachel Born, Michael J Boss, Linda F Barr |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 113
Issue 6
Pg. 2008-2017
(06 2022)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 34352198
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Analgesics, Opioid
(therapeutic use)
- Dizziness
- Enhanced Recovery After Surgery
- Humans
- Length of Stay
- Nausea
(drug therapy)
- Pain, Postoperative
(drug therapy, prevention & control)
- Retrospective Studies
|